253-52-1 | Phthalazine

Packsize	Purity	Availability	Price	Discounted Price
1g	98%	in stock	$10.00	$7.00
5g	98%	in stock	$16.00	$11.00
10g	98%	in stock	$29.00	$20.00
25g	98%	in stock	$49.00	$34.00

Description

• Catalog Number: AB78338
• Chemical Name: Phthalazine
• CAS Number: 253-52-1
• Molecular Formula: C8H6N2
• Molecular Weight: 130.1466
• MDL Number: MFCD00006908
• SMILES: c1ccc2c(c1)cnnc2

Computed Properties

• Complexity: 99.8
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 2
• XLogP3: 0.6

Literature

• 5-Bromo-phthalazine hemihydrate.

  Acta crystallographica. Section E, Structure reports online 20120801

• 1-(2,6-Diisopropyl-phen-oxy)-4-phenyl-phthalazine.

  Acta crystallographica. Section E, Structure reports online 20120801

• Ultrasound-promoted one-pot, three-component synthesis of spiro[indoline-3,1'-pyrazolo[1,2-b]phthalazine] derivatives.

  Molecules (Basel, Switzerland) 20120723

• Reactions of phthalazine, quinazoline, 4,7-phenanthroline and 2,3'-bipyridine with ruthenium carbonyl.

  Dalton transactions (Cambridge, England : 2003) 20120628

• Synthesis, vasorelaxant activity, and molecular modeling study of some new phthalazine derivatives.

  European journal of medicinal chemistry 20120601

• Ultrasound-promoted catalyst-free one-pot four component synthesis of 2H-indazolo[2,1-b]phthalazine-triones in neutral ionic liquid 1-butyl-3-methylimidazolium bromide.

  Ultrasonics sonochemistry 20120301

• Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons.

  The Journal of biological chemistry 20120217

• In vitro leishmanicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species.

  The Journal of antimicrobial chemotherapy 20120201

• A practical and direct comparison of intrinsic metabolic clearance of several non-CYP enzyme substrates in freshly isolated and cryopreserved hepatocytes.

  Drug metabolism and pharmacokinetics 20120101

• A catalytically silent FAAH-1 variant drives anandamide transport in neurons.

  Nature neuroscience 20120101

• Flavonoid glycosides isolated from unique legume plant extracts as novel inhibitors of xanthine oxidase.

  PloS one 20120101

• Some recent approaches of biologically active substituted pyridazine and phthalazine drugs.

  Current medicinal chemistry 20120101

• Inhibition of human liver aldehyde oxidase: implications for potential drug-drug interactions.

  Drug metabolism and disposition: the biological fate of chemicals 20111201

• 1-Benzoyl-4-(4-methyl-phen-yl)phthal-azine.

  Acta crystallographica. Section E, Structure reports online 20111201

• Hydrogen-bonded structures of the isomeric compounds of phthalazine with 3-chloro-2-nitrobenzoic acid, 4-chloro-2-nitrobenzoic acid and 4-chloro-3-nitrobenzoic acid.

  Acta crystallographica. Section C, Crystal structure communications 20111101

• Luminescent square-planar platinum(II) complexes with tridentate 3-bis(2-pyridylimino)isoindoline and monodentate N-heterocyclic ligands.

  Dalton transactions (Cambridge, England : 2003) 20110714

• Transition metal complexes of the novel hexadentate ligand 1,4-bis(di(N-methylimidazol-2-yl)methyl)phthalazine.

  Dalton transactions (Cambridge, England : 2003) 20110428

• Fourier transform microwave and millimeter wave spectroscopy of quinazoline, quinoxaline, and phthalazine.

  The Journal of chemical physics 20110421

• The discovery of phthalazinone-based human H1 and H3 single-ligand antagonists suitable for intranasal administration for the treatment of allergic rhinitis.

  Journal of medicinal chemistry 20110414

• (S)-2-Amino-2-(2-chloro-phen-yl)cyclo-hexa-none.

  Acta crystallographica. Section E, Structure reports online 20110401

• Biotransformation of quinazoline and phthalazine by Aspergillus niger.

  Journal of bioscience and bioengineering 20110301

• Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.

  Journal of medicinal chemistry 20110113

• Design and synthesis of selective and potent orally active S1P5 agonists.

  ChemMedChem 20101004

• Augmentation of the antileukemia potency of total-body irradiation (TBI) by a novel P-site inhibitor of spleen tyrosine kinase (SYK).

  Radiation research 20101001

• Associative and dissociative mechanisms in the formation of phthalazine bridged organodiplatinum(II) complexes.

  Inorganic chemistry 20100920

• Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor.

  Journal of medicinal chemistry 20100909

• Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives.

  European journal of medicinal chemistry 20100801

• Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines.

  Bioorganic & medicinal chemistry letters 20100801

• 2-[1-(3-Oxo-1,3-dihydro-2-benzofuran-1-yl)-1H-benzimidazol-2-yl]benzoic acid methanol solvate.

  Acta crystallographica. Section E, Structure reports online 20100801

• 4-Hydr-oxy-6-[(4-hydr-oxy-1-oxo-1,2-dihydro-phthalazin-6-yl)carbon-yl]phthalazin-1(2H)-one.

  Acta crystallographica. Section E, Structure reports online 20091201

• Phthalocyanine-C60 fused conjugates exhibiting molecular orbital interactions depending on the solvent polarity.

  Chemistry, an Asian journal 20091102

• Synthesis and antibacterial activity of some new heterocycles incorporating phthalazine.

  European journal of medicinal chemistry 20091101

• 3-Methyl-1,2,4-triazolo[3,4-a]phthalazine monohydrate.

  Acta crystallographica. Section E, Structure reports online 20091101

• Novel phthalazinyl derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis isocitrate lyase enzyme.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20090901

• Evaluation of solvent effects on protonation using NMR spectroscopy: implication in salt formation.

  International journal of pharmaceutics 20090730

• Dichloridobis(phenanthridine-κN)zinc(II).

  Acta crystallographica. Section E, Structure reports online 20090701

• Theoretical quest for photoconversion molecules having opposite directions of the electric dipole moment in S0 and S1 states.

  The Journal of chemical physics 20090514

• 2-(3-Oxo-1,3-dihydro-isobenzofuran-1-yl)-phthalazin-1(2H)-one.

  Acta crystallographica. Section E, Structure reports online 20090501

• S(N)(H) approach in the synthesis of nitronyl nitroxides.

  The Journal of organic chemistry 20090403

• Ultrasound assisted reactions of steroid analogous of anticipated biological activities.

  Ultrasonics sonochemistry 20090301

• Practical synthesis of a p38 MAP kinase inhibitor.

  The Journal of organic chemistry 20090116

• Microwave assisted reactions of some azaheterocylic compounds.

  Molecules (Basel, Switzerland) 20090115

• Site directed mutagenesis of amino acid residues at the active site of mouse aldehyde oxidase AOX1.

  PloS one 20090101

• Development of improved models for phosphodiesterase-4 inhibitors with a multi-conformational structure-based QSAR method.

  Current chemical genomics 20090101

• Discovery of highly selective and potent p38 inhibitors based on a phthalazine scaffold.

  Journal of medicinal chemistry 20081023

• Structural basis for ligand recognition at the benzodiazepine binding site of GABAA alpha 3 receptor, and pharmacophore-based virtual screening approach.

  Journal of molecular graphics & modelling 20081001

• Synthesis of 3,4-benzo-7-hydroxy-2,9-diazabicyclo[3.3.1]non-7-enes by cyclization of 1,3-bis(silyl enol ethers) with quinazolines.

  Organic & biomolecular chemistry 20080821

• Multiple surface plasmon resonances and near-infrared field enhancement of gold nanowells.

  Analytical chemistry 20080701

• A new class of luminescent tricarbonyl rhenium(I) complexes containing bridging 1,2-diazine ligands: electrochemical, photophysical, and computational characterization.

  Inorganic chemistry 20080519

• Conformation-activity relationship on novel 4-pyridylmethylthio derivatives with antiangiogenic activity.

  Bioorganic & medicinal chemistry letters 20080501

• N,N'-Bis(4-chloro-phen-yl)urea.

  Acta crystallographica. Section E, Structure reports online 20080501

• Synthesis of 1-/2-substituted-[1,2,3]triazolo[4,5-g]phthalazine-4,9-diones and evaluation of their cytotoxicity and topoisomerase II inhibition.

  Bioorganic & medicinal chemistry 20080415

• Role of phosphodiesterase 5 in synaptic plasticity and memory.

  Neuropsychiatric disease and treatment 20080401

• 2-(2-Hydroxy-ethyl)phthalazin-1(2H)-one.

  Acta crystallographica. Section E, Structure reports online 20080401

• (1R,2R)-4-Benzoyl-2-benzo-yloxy-1-phenyl-butyl imidazole-1-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20080301

• (2S,4'R,5'R)-(E)-tert-Butyl 2-acetyl-2-(2-oxo-5-phenyl-1,3-dioxolan-4-ylmeth-yl)-5-phenyl-pent-4-enoate.

  Acta crystallographica. Section E, Structure reports online 20080201

• A new structure-based QSAR method affords both descriptive and predictive models for phosphodiesterase-4 inhibitors.

  Current chemical genomics 20080101

• Phthalazin-1(2H)-one-picric acid (1/1).

  Acta crystallographica. Section E, Structure reports online 20080101

• Copper(I) cyanide networks: synthesis, luminescence behavior and thermal analysis. Part 1. Diimine ligands.

  Inorganic chemistry 20071015

• Efficiency improvement for sulfated ash determination by usage of a microwave muffle furnace.

  Journal of pharmaceutical and biomedical analysis 20070411

• [Synthesis and characterization of silver-intermediates in the development process of photothermographic material].

  Guang pu xue yu guang pu fen xi = Guang pu 20070401

• 1,4-Bis(alkylamino)benzo[g]phthalazines able to form dinuclear complexes of Cu(II) which as free ligands behave as SOD inhibitors and show efficient in vitro activity against Trypanosoma cruzi.

  Bioorganic & medicinal chemistry 20070301

• Luminescent hydrido-carbonyl clusters of rhenium containing bridging 1,2-diazine ligands.

  Inorganic chemistry 20061225

• 4-(Azolylphenyl)-phthalazin-1-amines: Novel inhibitors of VEGF receptors I and II.

  Chemical biology & drug design 20061201

• 1-(Azolyl)-4-(aryl)-phthalazines: novel potent inhibitors of VEGF receptors I and II.

  Chemical biology & drug design 20061101

• A dinucleating ligand related to the beta-diketiminates.

  Dalton transactions (Cambridge, England : 2003) 20060828

• Aqueous N-heterocyclization of primary amines and hydrazines with dihalides: microwave-assisted syntheses of N-azacycloalkanes, isoindole, pyrazole, pyrazolidine, and phthalazine derivatives.

  The Journal of organic chemistry 20060106

• Evaluation of apoptosis-induction by newly synthesized phthalazine derivatives in breast cancer cell lines.

  Asian Pacific journal of cancer prevention : APJCP 20060101

• Oxidative addition of methyl iodide to a new type of binuclear platinum(II) complex: a kinetic study.

  Inorganic chemistry 20051114

• Arylphthalazines: identification of a new phthalazine chemotype as inhibitors of VEGFR kinase.

  Bioorganic & medicinal chemistry letters 20051101

• Phthalazine PDE IV inhibitors: conformational study of some 6-methoxy-1,4-disubstituted derivatives.

  Bioorganic & medicinal chemistry 20050715

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• VEGF receptor kinase inhibitors: phthalazines, anthranilamides and related structures.

  Expert opinion on therapeutic patents 20050601

• Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.

  Journal of medicinal chemistry 20050210

• Synthesis and luminescence properties of lanthanide complexes incorporating a hydralazine-derived chromophore.

  Dalton transactions (Cambridge, England : 2003) 20050107

• A novel three-component reaction designed by the combinatorial method: heteroarenes, isothiocyanates and isocyanides.

  Molecular diversity 20050101

• Enzymatic catalysis of urea decomposition: elimination or hydrolysis?

  Journal of the American Chemical Society 20040929

• Synthesis and cytotoxicity of 1-substituted 2-methyl-1H-imidazo[4,5-g]phthalazine-4,9-dione derivatives.

  Bioorganic & medicinal chemistry 20040701

• Synthesis of 5-azaindolizine derivatives by the palladium-catalyzed intermolecular formal [3+2] cycloaddition of alkylidenecyclopropanes with 1,2-diazines.

  The Journal of organic chemistry 20040430

• Realization of unusual ligand binding motifs in metalated container molecules: synthesis, structures, and magnetic properties of the complexes [(LMe)Ni2(mu-L')]n+ with L'=NO3-, NO2-, N3-, N2H4, pyridazine, phthalazine, pyrazolate, and benzoate.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20040402

• Synthesis and characterization of Cu(2)(I,I), Cu(2)(I,II), and Cu(2)(II,II) compounds supported by two phthalazine-based ligands: influence of a hydrophobic pocket.

  Inorganic chemistry 20040308

• Human liver aldehyde oxidase: inhibition by 239 drugs.

  Journal of clinical pharmacology 20040101

• Potent inhibition of human liver aldehyde oxidase by raloxifene.

  Drug metabolism and disposition: the biological fate of chemicals 20040101

• Enzymatic oxidation of phthalazine with guinea pig liver aldehyde oxidase and liver slices: inhibition by isovanillin.

  Acta biochimica Polonica 20040101

• Modeling the syn disposition of nitrogen donors at the active sites of carboxylate-bridged diiron enzymes. Enforcing dinuclearity and kinetic stability with a 1,2-diethynylbenzene-based ligand.

  Inorganic chemistry 20031229

• Synthesis and structural characterization of 1-(D-glycosyloxy)phthalazines.

  Carbohydrate research 20031031

• Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors.

  Bioorganic & medicinal chemistry letters 20030804

• Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.

  Proteins 20030201

• Aldehyde-sequestering drugs: tools for studying protein damage by lipid peroxidation products.

  Toxicology 20021227

• Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase.

  Xenobiotica; the fate of foreign compounds in biological systems 20021001

• Phthalazine PDE4 inhibitors. Part 3: the synthesis and in vitro evaluation of derivatives with a hydrogen bond acceptor.

  Bioorganic & medicinal chemistry letters 20020107

• The reaction of fullerene C(60) with phthalazine: the mechanochemical solid-state reaction yielding a new C(60) dimer versus the liquid-phase reaction affording an open-cage fullerene.

  The Journal of organic chemistry 20011102

• Quantitative study of the structural requirements of phthalazine/quinazoline derivatives for interaction with human liver aldehyde oxidase.

  Chemical & pharmaceutical bulletin 20010901

• Phthalazine-based dinucleating ligands afford dinuclear centers often encountered in metalloenzyme active sites.

  Inorganic chemistry 20010226

• Phthalazine PDE4 inhibitors. Part 2: the synthesis and biological evaluation of 6-methoxy-1,4-disubstituted derivatives.

  Bioorganic & medicinal chemistry letters 20010108